Cardiac angiosarcoma should be considered in the differential diagnosis of bloody pericardial effusions, even with negative early investigations, as it carries a poor prognosis.
No takes yet. Share an insight, caveat, or question.
Supports early inclusion of cardiac angiosarcoma in bloody pericardial effusion differentials; leaves open the search for effective therapies given uniformly poor survival.
Chalhoub et al. (2012) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: